Phase II Feasibility Study of Gold Fiducial Markers forSurgical-Pathological Localisation and Chemotherapy ResponseAssessment in the Multi-Disciplinary Team Management ofOesophageal-Gastric Cancer
Phase 2
Completed
- Conditions
- Oesophageal - gastric cancerCancer - StomachCancer - Oesophageal (gullet)
- Registration Number
- ACTRN12613000387729
- Lead Sponsor
- Austin Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Age>18yrs with biopsy proven primary (non-recurrent) squamous cell carcinoma (SCC)or adenocarcinoma of the stomach discussed at the upper gastro-intestinal multidisciplinary team meeting (MDT) were considered eligible if they fulfilled the inclusion criteria. These criteria included cancer stage (T1-3,N0-1,M0-1a), ECOG 0 or 1, medically suitable for oeosphagectomy and chemotherapy and or chemoradiotherapy, and written informed consent.
Exclusion Criteria
Stage M1b
Contraindications to CT contrast e.g. severe chronic kidney disease, allergy to contrast
Contraindications to PET/CT e.g. claustrophobia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method